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Abstract
Background: In experimentally induced myocardial infarction, mild hypothermia (33–35°C) is
beneficial if applied prior to ischemia or reperfusion. Hypothermia, when applied after reperfusion
seems to confer little or no benefit. The mechanism by which hypothermia exerts its cell-protective
effect during cardiac ischemia remains unclear. It has been hypothesized that hypothermia reduces
the reperfusion damage; the additional damage incurred upon the myocardium during reperfusion.
Reperfusion results in a massive increase in blood flow, reactive hyperemia, which may contribute
to reperfusion damage. We postulated that hypothermia could attenuate the post-ischemic
reactive hyperemia.
Methods: Sixteen 25–30 kg pigs, in a closed chest model, were anesthetized and temperature was
established in all pigs at 37°C using an intravascular cooling catheter. The 16 pigs were then
randomized to hypothermia (34°C) or control (37°C). The left main coronary artery was then
catheterized with a PCI guiding catheter. A Doppler flow wire was placed in the mid part of the
LAD and a PCI balloon was then positioned proximal to the Doppler wire but distal to the first
diagonal branch. The LAD was then occluded for ten minutes in all pigs. Coronary blood flow was
measured before, during and after ischemia/reperfusion.
Results: The peak flow seen during post-ischemic reactive hyperemia (during the first minutes of
reperfusion) was significantly reduced by 43 % (p < 0.01) in hypothermic pigs compared to controls.
Conclusion: Mild hypothermia significantly reduces post-ischemic hyperemia in a closed chest pig
model. The reduction of reactive hyperemia during reperfusion may have an impact on cardiac
reperfusion injury.
Background
Coronary reperfusion injury is believed to occur during
reperfusion of an occluded coronary artery in the setting
of myocardial infarction. The existence of this injury is
still a matter of debate [1], but also the focus of a great
deal of research on how to limit the possible additional
cell death thought to occur during reperfusion [2]. The
mechanism of this proposed reperfusion injury is unclear
but several hypotheses have been proposed: oxygen free
radical formation, calcium overload, neutrophil-medi-
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ated myocardial and endothelial injury, progressive
decline in microvascular flow to the reperfused myocar-
dium, and depletion of high energy phosphate stores [3].
Although a number of pharmacological treatments,
aimed at the above mentioned mechanism, have been
tried in experimental settings, none have yet yielded pos-
itive results in a large randomized trial in man.
During a coronary artery occlusion, the area of the heart
supplied by the artery is deprived of its blood-supply.
Upon reperfusion there is a dramatic rise in coronary
blood flow, far above the baseline flow prior to the occlu-
sion [4]. This phenomenon, post ischemic reactive hyper-
emia, is somewhat of an enigma because the incurred
oxygen debt does not in itself justify the flow increase [5].
In experiments by Badeer et al., the excess coronary flow
measured during post ischemic reactive hyperemia was 4
times that of the incurred debt [6]. Although the peak flow
is greatly increased rapidly following reperfusion, it also
rapidly returns to baseline within a few minutes [7]. Sev-
eral factors have been implicated and the mechanism is
now thought to be multi-factorial involving adrenalin,
ADP/ATP, adenosine, substance P, and bradykinin but
there still exists an unaccountable rise in blood flow dur-
ing reperfusion [5,7-16].
Therapeutic mild hypothermia has experimentally in
large animals been shown to limit myocardial infarct size
if applied prior to reperfusion [17-19], but not following
reperfusion [19]. It has also been shown that the earlier
hypothermia is applied to an ischemic myocardium, the
more tissue stands to be salvaged [20]. Post hoc analyses
of the 2 large randomized hypothermia trials in man,
COOL-MI (O'Neill WW, on behalf of the COOL-MI inves-
tigators. Cooling as an adjunct to primary PCI for myocar-
dial infarction. Presented at Transcatheter Cardiovascular
Therapeutics (TCT) 2003, Washington DC, USA, Septem-
ber, 2003) and ICE-IT (Grines CL, on behalf of the ICE-IT
investigators. Intravascular cooling adjunctive to percuta-
neous coronary intervention for acute myocardial infarc-
tion. Presented at Transcatheter Cardiovascular
Therapeutics (TCT) 2004, Washington DC, USA, Septem-
ber, 2004), indicates that attaining a core temperature of
< 35°C before reperfusion is essential in order to reduce
myocardial infarct size. Unfortunately the mechanisms by
which mild hypothermia exerts its effect is still unknown,
although it is a common belief that the decrease in meta-
bolic demand in the hypothermic myocardium is one
explanation for the reduced infarction size. Thus, there is
a need to better understand the protective mechanisms of
hypothermia, in order to design future human trials in a
better way.
Since reactive hyperemia is an occurrence which immedi-
ately follows reperfusion, and thus potentially could be
involved in the development of a reperfusion injury, we
wanted to examine if reactive hyperemia could be affected
by hypothermia. We hypothesized that the large blood
flow seen during coronary post ischemic reactive hypere-
mia could be attenuated by mild systemic hypothermia
and that this may be a mechanism by which hypothermia
could reduce reperfusion injury.
Methods
Animals
16 healthy domestic male and female pigs weighing 25 kg
were fasted overnight with free access to water and were
premedicated with azaperone (Stresnil Vet., Leo; Helsing-
borg, Sweden), 2 mg/kg intramuscularly 30 min before
the procedure. After induction of anesthesia with thiopen-
tal 5–25 mg/kg (Pentothal, Abbott, Stockholm, Sweden),
the animals were orally intubated with cuffed endotra-
cheal tubes. A slow infusion of 1.25 µl/ml Fentanyl (Fen-
tanyl, Pharmalink AB, Stockholm, Sweden) in Ringer's
acetate solution was started at a rate of 1.5 ml/min and
adjusted as needed. Mechanical ventilation was then
established with a Siemens-Elema 300B ventilator in the
volume-controlled mode. Initial settings were: respiratory
rate of 15/min, tidal volume of 10 ml/kg, and positive
end-expiratory pressure of 5 cm H2O. Min volume was
subsequently adjusted in order to obtain normocapnia
(35–40 mm Hg). The animals were ventilated with a mix-
ture of dinitrous oxide (70%) and oxygen (30%).
Anesthesia was complemented with small intermittent
doses of 5 mg meprobamat (Mebumal, DAK, Copenha-
gen, Denmark) and thiopental (Pentothal, Abbott, Stock-
holm, Sweden), if needed.
A 6 F introducer sheath (Boston Scientific Scimed, Maple
Grove, MN, USA) was inserted into the surgically exposed
left femoral artery with the tip of the introducer located in
the Iliac Artery or the distal Abdominal Aorta. The side
port of the introducer was connected to a pressure trans-
ducer and balanced to atmospheric pressure with zero ref-
erence at the mid-axillary level for continuously
monitoring of the arterial pressure. A three-lead ECG was
displayed on the same monitor as the pressure curve
(78342 A, Hewlett and Packard GMBH. Boeblingen, Ger-
many).
A 12 F introducer sheath (Boston Scientific Scimed, Maple
Grove, MN, USA) was inserted into the surgically exposed
left Femoral Vein. A 10.7 F cooling (temperature control)
catheter (Celsius Control™, Innercool Therapeutic, San
Diego, CA, USA) was inserted through the sheath and
positioned in the Inferior Vena Cava.
A 12 F introducer sheath (Boston Scientific Scimed, Maple
Grove, MN, USA) was inserted into the surgically exposed
left External Jugular Vein. A short 10 F special catheter ofBMC Cardiovascular Disorders 2007, 7:5 http://www.biomedcentral.com/1471-2261/7/5
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our own design was used to catheterize the Azygos Vein.
Then a 6 F MPA coronary catheter (Boston Scientific Sci-
med, Maple Grove, MN, USA) was passed through the
catheter with the tip in the Azygos Vein, into the Coronary
Sinus, often with the help of a PT choice guide wire, (Bos-
ton Scientific Scimed, Maple Grove, MN, USA).
A 6 F introducer sheath (Boston Scientific Scimed, Maple
Grove, MN, USA) was inserted into the surgically exposed
left carotid artery upon which a 6F JL 3.5 Wiseguide™
(Boston Scientific Scimed, Maple Grove, MN, USA) was
inserted into the left main coronary artery and 10,000 IU
of Heparin was administered. An angiogram was obtained
using 8–10 ml of the contrast medium Omnipaque™ 300
mg I-/ml (Nycomed, Oslo, Norway) to ensure correct
positioning of the catheter. The catheter was used to place
a 0.014-inch, 12 MHz pulsed Doppler flow velocity trans-
ducer (Jometrics Flowire, Jomed NV) into the mid-por-
tion of the left anterior descending artery (LAD) and a
0.014-inch PT choice™ guidewire (Boston Scientific Sci-
med, Maple Grove, MN, USA) into the distal portion of
the LAD. A 3.0 × 20 mm over the wire Maverick™ angi-
oplasty balloon (Boston Scientific Scimed, Maple Grove,
MN, USA) was then positioned in the mid portion of the
LAD, proximal to the flow velocity transducer but distal to
the first diagonal branch, followed by the withdrawal of
the PT choice guidewire. Continuous coronary velocity
flow profiles were displayed and recorded using the Dop-
pler flow wire connected to a FloMap monitor (Cardio-
metrics, Mountain View, CA). Flow was measured in units
of average peak velocity (APV) in centimeters per second.
All radiological procedures were performed in an experi-
mental catheterization laboratory, (Shimadzu Corp.,
Kyoto, Japan). The diameter of the LAD was measured in
separate pigs during baseline and during reperfusion at
the same angle to ensure that a change in diameter did not
occur in the LAD.
In all 16 pigs baseline registrations were performed.
Regardless of initial temperature, all pigs were cooled or
warmed (as needed) to a baseline temperature of 37°C,
which was then maintained for 30 minutes. The pigs were
then randomized to the hypothermia group or to the con-
trol group using a simple randomization by drawing
folded notes out of a box which read "cool" or "warm".
The pigs randomized to hypothermia were then cooled
with the cooling catheter to a temperature of 34.0°C,
prior to balloon inflation, which was then maintained
until sacrifice. The pigs randomized to the control group
were actively maintained at 37°C using the endovascular
cooling catheter until sacrifice.
In all pigs, the LAD was then occluded distal to the first
diagonal branch by inflation of the angioplasty balloon
for a period of ten min. The coronary blood flow in the
LAD was measured before, during and after occlusion of
the LAD. During the reperfusion phase, flow was meas-
ured at every 10 sec. Flow was measured in average peak
velocity (APV) in cm/sec. Occlusion of the LAD was per-
formed only once in each pig.
Blood gases were collected through the MPA catheter in
the Coronary Sinus and the Femoral Artery sheath during
baseline, early ischemia (one minute after balloon infla-
tion in the LAD), early reperfusion (one minute following
balloon deflation in the LAD) and late reperfusion (ten
minutes following balloon deflation in the LAD).
Protocol
At baseline, measurements of blood pressure, pulse and
APV were performed. Blood pressure and pulse were
measured continuously with coronary blood flow and
APV analyzed once every ten seconds. A blood gas analysis
was performed at baseline and at one and five min post
reperfusion
Reagents
Unless otherwise stated, drugs were purchased from
Sigma Co, USA.
Ethics
The Ethics Committee of Lund University approved the
project (M 137-04).
Calculation and statistics
Calculations and statistics were performed using the
GraphPad Prism, version 4.0 software. Values are pre-
sented as mean ± s.e.m. Statistical significance was
accepted when P < 0.05 (two-tailed test). Two-way analy-
sis of variance (ANOVA) test followed by Bonferroni post
test was used.
Results
Coronary blood flow in the LAD increased dramatically
during the early reperfusion phase. Peak flow was
observed in both groups within 3 minutes following start
of reperfusion (deflation of the balloon). The peak flow
observed during post ischemic reactive hyperemia was sig-
nificantly reduced by 43% in the 8 pigs randomized to
hypothermia compared to the 8 pigs in the control group
(p < 0.01, Figure 1). There was no observed difference in
coronary flow between the groups during baseline or after
7 minutes from reperfusion.
As expected, there was a reduction in heart rate observed
among the pigs randomized to the hypothermia group
during the entire period of hypothermia (Figure 2A). The
difference in heart rate was maintained at the same level
during baseline, ischemia and reperfusion, and unaffected
by the increased coronary flow measured during reactiveBMC Cardiovascular Disorders 2007, 7:5 http://www.biomedcentral.com/1471-2261/7/5
Page 4 of 9
(page number not for citation purposes)
hyperemia. Systolic blood pressure was non-significantly
reduced in the hypothermia group, but the mean arterial
blood pressure (MAP) was similar or even slightly
increased in the reperfusion phase compared to the con-
trol group (Figure 2b).
Blood gas analysis showed a significant decrease in
peripheral arterial base excess (BE) at one and ten minutes
following reperfusion in the control group compared to
the hypothermic group, (Figure 3a). Samples collected in
the Coronary Sinus showed a prominent reduction in BE
in both groups at one minute after reperfusion. BE did not
differ significantly between the groups (Figure 3b). Other
measurements of blood gas analysis did not show any sig-
nificant differences in regard to O2 saturation or pH
between the groups (not shown).
In separate pigs (n = 4) the diameter of the coronary ves-
sels was measured at the baseline temperature of 37°C (n
= 4) and at the hypothermic target temperature of 34°C (n
= 2). The vessel diameter was again measured during con-
trast injection in the LAD in both hypothermic and con-
trol pigs during early and late reperfusion. The diameter of
the LAD never varied more than 10% from baseline, for
each pig, and in our experiments compensation for diam-
eter changes did not markedly influence the results.
Discussion
We have shown that coronary blood flow during post
ischemic reactive hyperemia is reduced nearly by half in
the animals treated with mild hypothermia (34°C) com-
pared to controls (37°C).
In general, hypothermia is thought to reduce the meta-
bolic needs of cells and specifically perhaps by reducing
the oxygen demand in the hypothermic tissues [21-24].
However, little is known about the actual mechanisms by
which hypothermia can reduce cell death in ischemic tis-
sues and the reduced oxygen demand does not fully
explain the positive effects of hypothermia [25].
Hypothermia has been shown to limit infarct size if insti-
tuted during ischemia and reperfusion [17-19], we there-
fore postulated that the protective effect of hypothermia is
in part mediated by a reduced reperfusion injury. It is still
controversial weather reperfusion injury exists as an
entity, but also the focus of a great deal of research [1,2].
If there is such a thing as reperfusion injury, one of several
events taking place during reperfusion which could poten-
tially cause reperfusion injury is the large increase in cor-
onary flow that occurs during reperfusion (postischemic
reactive hyperemia). We therefore wanted to examine if
this phenomenon could be affected by hypothermia and
thus explain one possible mechanism, or effect, by which
hypothermia may exert its protective effect during reper-
fusion.
The closed chest pig model was chosen to lessen the
trauma to the animals and may confer fewer confounding
factors than an open chest model. Since the nature of our
experiment focused solely on the phenomenon of pos-
tischemic reactive hyperemia, we decided on a 10 minute
occlusion time which is an established time period for
studying reactive hyperemia in both animals and man.
Hypothermia has long been established as a method to
limit cell-death due to prolonged ischemia, chiefly in car-
diovascular surgery and by neurosurgeons for head and
spinal cord injuries as well as during aneurysm repair sur-
gery [26,27]. Recent developments have focused on treat-
ing successfully resuscitated, but still comatose, cardiac
arrest victims, with hypothermia to improve neurologic
outcome. This has led to a revision of guidelines to incor-
porate cooling of cardiac arrest victims at a class IIb level
[28].
Several animal studies have shown that hypothermia
reduces infarct size in the setting of myocardial infarct
(usually caused by the ligation of LAD). Duncker et al.
found a correlation between infarct size and temperature
with the smallest infarct size found at the lowest tempera-
ture [18]. Other reports have indicated a positive temper-
Coronary reactive hyperemia Figure 1
Coronary reactive hyperemia. The figure illustrates cor-
onary blood flow expressed as average peak velocity (APV), 
in cm/s, in the LAD at baseline samples (A), at samples during 
the LAD occlusion (ischemia) (B), and at 10 sec intervals dur-
ing the time of the reperfusion period (C), i.e., the phase of 
post-ischemic reactive hyperemia. The hypothermic group (n 
= 8) had a significant 43% lower peak flow than the normoth-
ermic group (n = 8) during the period of reactive hyperemia. 
There was no observed difference in coronary flow between 
the groups during baseline or after 7 minutes from reper-
fusion.
Coronary reactive hyperemia
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Heart rate and mean arterial pressure during baseline, ischemia and reperfusion Figure 2
Heart rate and mean arterial pressure during baseline, ischemia and reperfusion. Heart rate (HR) was measured 
during baseline, ischemia, and reperfusion in both the normothermic (n = 8) and the hypothermic (n = 8) pigs. During the 
entire period of hypothermia HR was lower in the hypothermic group (A). Mean arterial pressure, expressed as mm/Hg, was 
similar, and reduced in both groups during ischemia and reperfusion compared to baseline (B).
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Base excess (BE) collected in a peripheral artery and the Coronary Sinus Figure 3
Base excess (BE) collected in a peripheral artery and the Coronary Sinus. Base excess (BE) was measured in a 
peripheral artery (A) and in the Coronary Sinus (CS), (B). There was no difference between normothermic (n = 8) and hypo-
thermic pigs at baseline. During early (+1 minute) and late (+10 minutes) reperfusion there was a significant reduction in BE in 
the normothermic group in samples from the peripheral artery (A). In samples from the CS, there was a marked reduction in 
BE in both groups during early reperfusion, which then nearly returned back to baseline at late reperfusion with no difference 
between the groups (B).
A
A                   B                    C
A= early ischemia (+1 min)
B= early reperfusion (+1 min)
C= late reperfusion (+10 min)
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ature-related effect of hypothermia in relation to infarct
size [17,19,20,29-31]. On the contrary Maeng et al. found
no benefit of hypothermia induced in conjunction with,
or after reperfusion [19]. Others have also shown in small
animal models that the earlier hypothermia is applied to
ischemic myocardial tissues the lesser the infarct size will
be, and that this effect can be further enhanced by precon-
ditioning [20,32]. To date, hypothermia has been tested
in five human trials in the setting of myocardial infarction
with planned PCI as reperfusion method (COOL MI, ICE-
IT, NICAMI [33], LOWTEMP [34] and a study by Dixon et
al [35]). The NICAMI and the LOWTEMP studies as well
as the study by Dixon were only feasibility trials, whereas
the randomized trials COOL MI and ICE-IT were designed
to test if a reduction of final infarct at size, by 30-day
SPECT analysis, could be attained by treatment with mild
hypothermia.
Unfortunately, both COOL MI and ICE-IT were negative
trials. At first glance this should have put an end to further
cooling trials in the setting of acute MI. However, in both
trials, only a minority of patients randomized to cooling
reached the target temperature prior to reperfusion, and
the few patients that did reach target temperature prior to
reperfusion exhibited a significant or strong reduction in
myocardial infarct size at 30 days compared to control-
patients, especially among patients with anterior infarcts.
The result of the two trials is thus in accordance with the
results found in preceding animal studies which exempli-
fies the importance of reaching target temperature prior to
reperfusion of completely occluded vessels. A sixth
human Trial, COOL MI II [36], has recently been started
in lieu of these findings. In this trial, only patients with
anterior acute MI's will be randomized to intravascular
cooling or control, and cooling will be initiated earlier
than in COOL-MI I.
The previous animal and human trials have all looked at
the cause and effect of using hypothermia as a means to
reduce myocardial infarct size. However, the mechanism
by which hypothermia exerts its myocardial protective
effect has been explained mainly by a reduction in oxygen
consumption [22,23,33,34,37].
Postconditioning as a means to reduce infarct size has
recently been successfully performed in several animal
experiments and one trial in man [38-41]. There have also
been some negative or ambiguous reports concerning the
effects of postconditioning [42,43]. Interestingly, the
reduced flow often employed during the first couple of
minutes (cycles of occlusion and reperfusion) during
reperfusion in postconditioning experiments may cause a
similar effect to that of the blunted reperfusion flow
observed in the very early phase of hypothermia in our
experiment. We found that hypothermia reduces the un-
proportionally large coronary flow seen during post
ischemic reactive hyperemia in the LAD, in a closed chest
porcine myocardial infarct model. This finding may
explain one of the effects by which hypothermia can
reduce infarct size if attained prior to reperfusion.
The reason why hypothermia reduces reactive hyperemia
is not fully elucidated. It is probably mediated by a reduc-
tion in the release of dilatory mediators, but it could be
caused by a reduced responsiveness in the endothelium
and vascular smooth muscle cells.
Hypothermia also seems to better maintain BE as meas-
ured in the peripheral artery (internal Iliac Artery or distal
abdominal Aorta) with no significant differences seen in
the coronary venous outflow in the coronary sinus. One
could speculate if the difference in BE could have influ-
enced the results of coronary flow during reactive hypere-
mia. However it is well established that the vascular bed
of the coronary circulation tends to dilate in response aci-
dosis and it has been suggested that a decrease in extracel-
lular pH could be involved in coronary flow regulation
during hypoxia, ischemia, and increased metabolic
demand [44,45]. Thus the significantly lower arterial BE
observed in the control group could potentially translate
into a higher coronary flow compared to the hypothermic
group. However, there was no observed difference in pH,
thus making it unlikely that the difference in BE levels
would significantly contribute to a substantial difference
in coronary flow.
The heart rate (HR) of the pigs in the hypothermic group
was clearly lower compared to pigs in the normothermic
group during the entire phase of hypothermia. During
mild hypothermia in pigs (and humans) a temperature
dependent decline in heart rate is accompanied by an
increase in stroke volume and may actually increase car-
diac output according to Weisser et al. and others [17,46],
while on the other hand coronary flow remains
unchanged during hypothermia [24]. However, although
heart rate declines during hypothermia, this is an inde-
pendent mechanism unrelated to the cardio-protective
effects (i.e. infarct size reduction) of hypothermia [47,48].
In regard to blood pressure, the hypothermic group of
pigs showed no difference in mean arterial pressure
(MAP) even though a general decline in MAP was
observed in both groups mainly during ischemia.
Conclusion
Hypothermia reduces the un-proportionally large coro-
nary flow seen during post ischemic reactive hyperemia in
the LAD, in a closed chest porcine myocardial infarct
model. This finding may explain one of the effects by
which hypothermia can reduce infarct size if attained
prior to reperfusion. Further research into the infarct-BMC Cardiovascular Disorders 2007, 7:5 http://www.biomedcentral.com/1471-2261/7/5
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reducing mechanisms of hypothermia is warranted if we
are to use hypothermia in the clinical setting of myocar-
dial infarction.
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